Form 4: Seer Director Nicolas Roelofs Awarded Significant Equity Grant
Insider Transaction Report
Seer, Inc. Director Nicolas H. Roelofs, PHD, has been granted 17,083 restricted stock units and options to purchase 25,416 shares of Class A Common Stock, aligning his interests with shareholders.
Summary
- Nicolas H. Roelofs, PHD, a Director of Seer, Inc. (SEER), acquired 17,083 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) on July 7, 2025, bringing his direct beneficial ownership to 74,996 shares.
- The RSUs vest on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
- Additionally, Mr. Roelofs was granted options to purchase 25,416 shares of Class A Common Stock on July 7, 2025, with an exercise price of $2.18 per share.
- These stock options also vest on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders, and have an expiration date of July 7, 2035.
Sentiment
Score: 6
Explanation: The document reports a routine equity grant to a director, which is generally a positive sign of alignment between management and shareholder interests, but does not contain information that would significantly alter the company's financial outlook or operations.
Positives
- The equity grants to Director Nicolas H. Roelofs align his financial interests more closely with those of Seer, Inc.'s shareholders, potentially incentivizing long-term value creation.
- The grants represent a commitment by the company to retain and compensate key leadership through equity, which is a common practice in publicly traded companies.
Future Outlook
The vesting schedules for the restricted stock units and stock options indicate that the equity will become exercisable or owned outright on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders, providing a future incentive for the director.
Industry Context
Equity grants to directors and executives are a standard component of compensation packages across various industries, particularly in technology and life sciences, aiming to align leadership incentives with company performance and shareholder returns.
Comparison to Industry Standards
- The grant of Restricted Stock Units (RSUs) and stock options to a director is a common compensation practice, consistent with industry standards for attracting and retaining experienced board members.
- The vesting schedule, tied to a specific future date or the next annual meeting, is typical for such equity awards, providing a long-term incentive.
Related Party Transactions
- The transaction involves an equity grant to Nicolas H. Roelofs, PHD, a Director of Seer, Inc., which is a standard form of compensation for a related party.
Stakeholder Impact
- Shareholders: The equity grant aligns the director's interests with shareholders, potentially leading to more focused efforts on long-term company performance.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- The Restricted Stock Units and stock options will vest on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
Key Dates
| Date | Description |
|---|---|
| 07/07/2025 | Date of transaction for both Restricted Stock Units (RSUs) and stock options acquisition. |
| 07/09/2025 | Date the Form 4 was signed by power of attorney. |
| 07/07/2026 | Earliest vesting date for both the Restricted Stock Units and stock options. |
| 07/07/2035 | Expiration date for the acquired stock options. |
Keywords
Seer Inc., SEER, Form 4, SEC filing, insider transaction, director compensation, equity grant, restricted stock units, RSUs, stock options, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.